Vlad Coric - Insider Trading & Ownership

Entity
Individual
Location
C/O Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven, Connecticut
Summary
The estimated net worth of Vlad Coric is at least $129 M dollars as of May 3, 2024. Vlad Coric is the Chief Executive Officer, Director of Biohaven Ltd. and owns shares of Biohaven Ltd. (BHVN) stock worth about $129 M. Vlad Coric is the Director of Revance Therapeutics, Inc. and owns shares of Revance Therapeutics, Inc. (RVNC) stock worth about $79 K.
All Insider Reports
All Insider Reports

Ownership of Vlad Coric

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BHVN Biohaven Ltd. Chief Executive Officer, Director $129 M +$15 M +13.2% Apr 22, 2024
RVNC Revance Therapeutics, Inc. Director $79 K May 1, 2024
BHVN Biohaven Pharmaceutical Holding Co Ltd. Chief Executive Officer, Director Oct 3, 2022
AKLI Akili, Inc. Director Jun 29, 2021

Insider Transactions Reported by Vlad Coric:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership